Drug · DIN 02436418
MODERIBA
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since November 26, 2018; first marketed February 19, 2015.
- Drug Identification Number (DIN)
- 02436418
- Company (DIN owner)
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ribavirin J05AP01
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RIBAVIRIN | 400 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 16, 2015: NOC 16537New Drug Submission (NDS)
Other DINs named MODERIBA
- DIN 02436396 · Cancelled Post Market
- DIN 02436426 · Cancelled Post Market